Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.9 USD | +2.79% | -1.53% | -1.43% |
Apr. 02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
Mar. 29 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
19.43M | - | - | - | - | - | |
684B | ||||||
568B | ||||||
361B | ||||||
329B | ||||||
284B |
- Stock Market
- Equities
- KALA Stock
- Charts KALA BIO, Inc.
- Sector Chart